Skip to main content
Clinical Epigenetics logoLink to Clinical Epigenetics
. 2023 Jan 6;15:3. doi: 10.1186/s13148-022-01405-5

Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker

Patricia Johansson 1,, Teresa Laguna 2,, Julio Ossowski 3,4, Vera Pancaldi 5,6, Martina Brauser 1, Ulrich Dührsen 7, Lara Keuneke 3, Ana Queiros 9, Julia Richter 8, José I Martín-Subero 9,10, Reiner Siebert 3,12, Brigitte Schlegelberger 4, Ralf Küppers 1, Jan Dürig 11, Eva M Murga Penas 3, Enrique Carrillo-de Santa Pau 2, Anke K Bergmann 4
PMCID: PMC9824968  PMID: 36609404

Correction to: Clinical Epigenetics (2022) 14:148 10.1186/s13148-022-01362-z

Following publication of the original article [1], the author noticed an error in the figure. In the published version, the image of Fig. 5 has been repeated twice. The author has informed to remove the duplicated image during correction process. The typesetter has inadvertently missed to correct the figure. However, the text citation and caption of the figure seem to be correct. The corrected Fig. 5 has been published with this erratum.

Fig. 5.

Fig. 5

Interaction of the gene BCL11B with other genes in CD8+ cells. BCL11B long-range interactions from Promoter Capture Hi-C for total CD8-positive T cells (red: BCL11B–C14orf64 (LINC01550) interactions). Genomic regions are depicted in blue circles (promoter region) or blue square (enhancer region)

The original has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Patricia Johansson, Email: patricia.johansson@uk-essen.de.

Teresa Laguna, Email: teresa.laguna@imdea.org.

Reference

  • 1.Bigouret V, Hoffmann T, Arlettaz L, Villard J, Colonna M, Ticheli A, et al. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood. 2003;101:3198–3204. doi: 10.1182/blood-2002-08-2408. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Epigenetics are provided here courtesy of BMC

RESOURCES